Results 181 to 190 of about 13,343 (204)

PREDICTIVE FACTORS OF THYROID CARCINOMA IN NON-TOXIC MULTINODULAR GOITRE

Acta Clinica Belgica, 2004
C Beguin, J P Squifflet, P de Nayer
exaly  

Multinodular goitre: ‘much more to it than simply iodine deficiency’

Best Practice & Research Clinical Endocrinology & Metabolism, 2000
Michael Derwahl, M Derwahl, H Studer
exaly  

DO THYROID-STIMULATING IMMUNOGLOBULINS CAUSE NON-TOXIC AND TOXIC MULTINODULAR GOITRE?

Lancet, The, 1978
I M Jackson, Seymour Reichlin, S Reichlin   +2 more
exaly  

Optimal surgical treatment for bilateral multinodular goitre

Surgical Practice, 2007
Sasa Radenković, Aleksandar Karanikolic
exaly  

Comparison of the Complications of Subtotal, Near Total and Total Thyroidectomy in the Surgical Management of Multinodular Goitre

Endocrine Journal, 2005
Serdar Özbaş, Atıl Çakmak, Savas Kocak   +2 more
exaly  

Induction of TSH-Receptor Antibodies in Patients with Toxic Multinodular Goitre by Radioiodine Treatment

Hormone and Metabolic Research, 2002
H Wallaschofski
exaly  

TSH-Receptor Autoantibodies - Differentiation of Hyperthyroidism between Graves' Disease and Toxic Multinodular Goitre

Experimental and Clinical Endocrinology and Diabetes, 2004
T Lohmann, H Wallaschofski, T Kuwert
exaly  

THYROID-STIMULATING IMMUNOGLOBULINS DO NOT CAUSE NON-AUTONOMOUS, AUTONOMOUS, OR TOXIC MULTINODULAR GOITRES

Lancet, The, 1979
J W F Elte, D van der Heide, J W Elte
exaly  

A double-blind randomised trial to evaluate the effect of anastrozole for the treatment of non-toxic multinodular goitre

International Journal of Clinical Practice, 2006
C Yiangou, M H Cummings, J S Knight
exaly  

Multinodular goitre is a gateway for molecular testing of DICER1 syndrome

Clinical Endocrinology, 2019
Philippe J Caron, Frédérique Savagner, Marion Gambart   +2 more
exaly